{"organizations": [], "uuid": "b9513fe376d7bceb513d195329f3d6716de14e8d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180326.html", "section_title": "Archive News &amp; Video for Monday, 26 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-mereo-biopharma-files-for-proposed/brief-mereo-biopharma-files-for-proposed-global-offering-idUSFWN1R8020", "country": "US", "domain_rank": 408, "title": "BRIEF-Mereo Biopharma Files For Proposed Global Offering", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-26T14:45:00.000+03:00", "replies_count": 0, "uuid": "b9513fe376d7bceb513d195329f3d6716de14e8d"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-mereo-biopharma-files-for-proposed/brief-mereo-biopharma-files-for-proposed-global-offering-idUSFWN1R8020", "ord_in_thread": 0, "title": "BRIEF-Mereo Biopharma Files For Proposed Global Offering", "locations": [], "entities": {"persons": [{"name": "cantor fitzgerald", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "mereo biopharma group plc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "jmp securities llc", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 26 (Reuters) - Mereo Biopharma Group Plc:\n* ‍FILING OF REGISTRATION STATEMENT ON FORM F-1 WITH U.S. SEC RELATING TO A PROPOSED INITIAL PUBLIC OFFERING OF ITS AMERICAN DEPOSITARY SHARES​\n* ‍ALL ADSS AND ORDINARY SHARES TO BE SOLD IN GLOBAL OFFERING WILL BE OFFERED BY COMPANY​\n* NO.OF SHARES TO BE REPRESENTED BY EACH ADS, NO OF ADSS & ORDINARY SHARES TO BE OFFERED, PRICE RANGE FOR OFFERING HAVE NOT YET BEEN DETERMINED​\n* ‍COWEN AND COMPANY, LLC, BMO CAPITAL MARKETS CORP. AND RBC CAPITAL MARKETS, LLC ARE ACTING AS BOOK-RUNNING MANAGERS FOR GLOBAL OFFERING​\n* ‍JMP SECURITIES LLC IS ACTING AS LEAD MANAGER AND CANTOR FITZGERALD EUROPE IS ACTING AS CO-MANAGER​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-26T14:45:00.000+03:00", "crawled": "2018-03-27T11:44:31.004+03:00", "highlightTitle": ""}